“In COVID-19 focus groups, participants have said, ‘I’m not getting tested. That’s how you get COVID-19.'” — Tiffany Osborne, director of community engagement for the Minority Health & Health Disparities Research Center in Birmingham, Alabama, on the challenges for COVID-19 testing programs in underserved communities.
“A lot of times people will pooh-pooh observational data, but this is exactly the type of data that we need.” — Ajay Kirtane, MD, of NewYork-Presbyterian/Columbia University Medical Center in New York City, on a study of heart attack outcomes in COVID-19 patients.
“In 30 years of near-infrared spectroscopy, I haven’t seen too many drugs that look like that.” — Robert Lodder, PhD, of the University of Kentucky College of Pharmacy in Lexington, on a petition to the FDA to recall certain formulations of the injectable diuretic acetazolamide.
“Whether we are overestimating or underestimating COVID-19 deaths often depends on how carefully we look.” — Harold Sanchez, MD, of Yale School of Medicine/Bridgeport Hospital in Connecticut, discussing “death from” versus “death with” coronavirus infection.
“There’s a huge knowledge gap and no way clinicians can fall back on a specified dosing regimen.” — Alan Bell, MD, of the University of Toronto, discussing new recommendations for using medical cannabis to treat chronic pain.
“They can go to a gastroenterologist in-network, at a surgical facility in-network, and still get a surprise bill from someone who they may not even have known was involved in their procedure.” — Karen Joynt Maddox, MD, of Washington University School of Medicine in St. Louis, on frequency of surprise billing for colonoscopies.